Digital Therapeutics Market By Product (Software, Devices), By Application (Cardiovascular Diseases, Central Nervous System (CNS) Disease, Diabetes, Gastrointestinal Disorders (GID), Mental Health, Neurology, Obesity, Ophthalmology, Respiratory Diseases, Smoking Cessation, Others ), By Distribution Channel (Business to Business, Business to Customer ), By End Users (Patients, Healthcare Providers, Payers, Employers, Other (Fitness and Wellness Centers, Gym, Etc.), By Region (U.S., Canada, Mexico, Rest of North America, France, UK, Germany, Spain, Italy, Nordic Countries, The Benelux Union, Rest of Europe, China, Japan, India, Australia, New Zealand, South Korea Southeast Asia, Rest of Asia Pacific, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of MEA, Brazil, Argentina Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2019 – 2027

Report ID :AMI-199 | Category : Healthcare It | Published Date : March, 2019 | Pages : 402 | Format :PDF
Buy Now!
Request Sample Ask For Discount Enquiry Before Buying 
Industry Trends
Global digital therapeutics market was valued at US$ 1658.3 million in 2018 and is expected to reach US$ 9,121.8 million by 2027 growing at an estimated CAGR of 21.1% over the forecast period. Growing need to control healthcare costs along with rising incidence of chronic diseases are factors that assist the global digital therapeutics market. Digital therapeutics is essentially deliver evidence-based therapeutic interventions to patients to manage, treat, or prevent a chronic disease or disorder. The basal insulin dose calculator for patients suffering from Type 2 diabetes is an ideal instance for digital therapeutics. 
The increasing demand for patient specific outcomes by healthcare agencies is another factor assisting the growth of digital therapeutics market. Traditional pharmaceutical and medtech companies can make the decision to capitalize on the opportunistic factors presented by digital therapeutics. The sooner the entry, the greater the potential. The first-mover advantage will allow life science organizations to shape and define the industry. Some of the pharmaceutical and med-tech companies are teaming with other companies to build digital capabilities either through acquisition strategy or licensing them from other companies. Such factors is anticipated to aid the overall growth of digital therapeutics market.
However, most of the pharma companies have not yet ventured in digital therapeutics market. This is mainly because they are trying to be more cautious in the highly regulated pharma industry. However, if this organizations shy away from this great opportunity for a longer period, they will risk losing crucial market share to the emerging healthcare technology companies. With such a technological innovation, pharmaceutical and medical device multinationals in the coming years will not just sell drugs to healthcare professional but also provide a bundle of digital therapies, medicines and services for the benefit of patients, healthcare professional as well as healthcare payers.
However, lack of awareness among consumers regarding digital therapeutics is one of the factors critically impacting the market growth. Delivering prevention along with awareness information through text message or some online media portal can effectively improve the consumer base of digital therapeutics. The pregnant women in Mali has helped to reduce maternal and perinatal mortality by almost 30% through the penetration of digital therapeutics.
North America accounted for more than 40% of the global digital therapeutics market. The company named Big Health is working with more than two dozen self-insured corporations in the United States to offer Sleepio to their employees. This initiative will help in closing the treatment gap of people suffering from chronic insomnia. Pear Therapeutics based in Boston and San Francisco developed prescription-based digital treatments for substance use disorder, schizophrenia, generalized anxiety disorder and post-traumatic stress disorder. The company’s reSET therapy for treatment of substance use disorders is the first prescription digital therapeutic cleared by the Food and Drug Administration (FDA).
The report provides both, qualitative and quantitative research of global digital therapeutics market, as well as provides worthy insights into the rational scenario and favored development methods adopted by key contenders. The report also offers extensive research on the key players in global diesel engine and gas engine market and detailed insights on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by the major players are also recognized and analyzed in the report. For each company, the report recognizes its headquarter, competitors, product/service type, application and specification, pricing, and gross margin.
Global Digital Therapeutics Market Revenue, 2019 - 2027
Digital Therapeutics Market
Competitive Landscape
The primary market participants in global digital therapeutics market include Adherium, BigHealth, BLUE MESA HEALTH, CANARY HEALTH, Chrono Therapeutics Inc., Diabetes Digital Media Ltd, Digital Therapeutics, Inc., Dthera Sciences, Firstbeat, GINGER.IO, Glooko, Inc., Limbix , Livongo Health, MANGO HEALTH, Merck & Co., Inc., Noom, Inc., Novartis AG, Omada Health, Inc., Propeller Health, Proteus Digital Health, WellDoc, Inc. among others.
Global Digital Therapeutics Market
By Products
  • Software
  • Devices
By Application
  • Cardiovascular Diseases
  • Central Nervous System (CNS) Disease
  • Diabetes
  • Gastrointestinal Disorders (GID)
  • Mental Health
  • Neurology
  • Obesity
  • Ophthalmology
  • Respiratory Diseases
  • Smoking Cessation
  • Others
By Distribution Channel 
  • Business to Business
  • Business to Customer
By End User
  • Patients
  • Healthcare Providers
  • Payers
  • Employers
  • Other (Fitness and Wellness Centers, Gym, Etc.)
By Geography
  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  •  Latin America
                                                
Key Questions



Request Sample



Report Customization



Request for Customization

1.    Market Scope

1.1. Market Segmentation

1.2. Years Considered

1.2.1. Historic Years: 2013 - 2017

1.2.2. Base Year: 2018

1.2.3. Forecast Years: 2019 – 2027

2.    Key Target Audiences

3.    Research Methodology

3.1. Primary Research

3.1.1. Research Questionnaire

3.1.2. Global Percentage Breakdown

3.1.3. Primary Interviews: Key Opinion Leaders (KOLs)

3.2. Secondary Research

3.2.1. Paid Databases

3.2.2. Secondary Sources

3.3. Market Size Estimates

3.3.1. Top-Down Approach

3.3.2. Bottom-Up Approach

3.4. Data Triangulation Methodology

3.5. Research Assumptions

4.    Recommendations and Insights from AMI’s Perspective**

5.    Holistic Overview of Digital Therapeutics Market

6.    Market Synopsis:  Digital Therapeutics Market

7.    Digital Therapeutics Market Analysis: Qualitative Perspective

7.1. Introduction

7.1.1. Product Definition

7.1.2. Industry Development

7.2. Market Dynamics

7.2.1. Drivers

7.2.2. Restraints

7.2.3. Opportunities

7.2.4. Challenges

7.3. Trends in Digital Therapeutics Market

7.4. Market Determinants Radar Chart

7.5. Macro-Economic and Micro-Economic Indicators: Digital Therapeutics Market

7.6. Industry Gross Margin Overview

7.7. Porter’s Five Force Analysis

7.8. PESTEL Analysis

7.9. Value Chain Analysis

7.10. Pricing Analysis, By Region (2018)

7.10.1. North America

7.10.1.1.  U.S

7.10.1.2.  Canada

7.10.1.3.  Mexico

7.10.2. Europe

7.10.2.1.  France

7.10.2.2.  The UK

7.10.2.3.  Spain

7.10.2.4.  Germany

7.10.2.5.  Italy

7.10.2.6.  Nordic Countries

7.10.2.6.1. Denmark

7.10.2.6.2. Finland

7.10.2.6.3. Iceland

7.10.2.6.4. Sweden

7.10.2.6.5. Norway

7.10.2.7.  Benelux Union

7.10.2.7.1. Belgium

7.10.2.7.2. The Netherlands

7.10.2.7.3. Luxembourg

7.10.3. Asia Pacific

7.10.3.1.  China

7.10.3.2.  Japan

7.10.3.3.  India

7.10.3.4.  New Zealand

7.10.3.5.  Australia

7.10.3.6.  South Korea

7.10.3.7.  Southeast Asia

7.10.3.7.1. Indonesia

7.10.3.7.2. Thailand

7.10.3.7.3. Malaysia

7.10.3.7.4. Singapore

7.10.3.7.5. Rest of Southeast Asia

7.10.4. Middle East and Africa

7.10.4.1.  Saudi Arabia

7.10.4.2.  UAE

7.10.4.3.  Egypt

7.10.4.4.  Kuwait

7.10.4.5.  South Africa

7.10.5. Latin America

7.10.5.1.  Brazil

7.10.5.2.  Argentina

8.    Global Digital Therapeutics Market Analysis and Forecasts, 2019 – 2027

8.1. Overview

8.1.1. Global Digital Therapeutics Market Revenue (US$ Mn)

8.2. Global Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Products

8.2.1. Software

8.2.1.1.    Definition

8.2.1.2.    Market Penetration, 2018

8.2.1.3.    Market Estimation, 2013 – 2018

8.2.1.4.    Market Forecast, 2019 – 2027

8.2.1.5.    Compound Annual Growth Rate (CAGR)

8.2.1.6.    Regional Bifurcation

8.2.1.6.1. North America

8.2.1.6.1.1. Market Estimation, 2013 – 2018

8.2.1.6.1.2. Market Forecast, 2019 – 2027

8.2.1.6.2. Europe

8.2.1.6.2.1. Market Estimation, 2013 – 2018

8.2.1.6.2.2. Market Forecast, 2019 – 2027

8.2.1.6.3. Asia Pacific

8.2.1.6.3.1. Market Estimation, 2013 – 2018

8.2.1.6.3.2. Market Forecast, 2019 – 2027

8.2.1.6.4. Middle East and Africa

8.2.1.6.4.1. Market Estimation, 2013 – 2018

8.2.1.6.4.2. Market Forecast, 2019 – 2027

8.2.1.6.5. Latin America

8.2.1.6.5.1. Market Estimation, 2013 – 2018

8.2.1.6.5.2. Market Forecast, 2019 – 2027

8.2.2. Devices

8.2.2.1.    Definition

8.2.2.2.    Market Penetration, 2018

8.2.2.3.    Market Estimation, 2013 – 2018

8.2.2.4.    Market Forecast, 2019 – 2027

8.2.2.5.    Compound Annual Growth Rate (CAGR)

8.2.2.6.    Regional Bifurcation

8.2.2.6.1. North America

8.2.2.6.1.1. Market Estimation, 2013 – 2018

8.2.2.6.1.2. Market Forecast, 2019 – 2027

8.2.2.6.2. Europe

8.2.2.6.2.1. Market Estimation, 2013 – 2018

8.2.2.6.2.2. Market Forecast, 2019 – 2027

8.2.2.6.3. Asia Pacific

8.2.2.6.3.1. Market Estimation, 2013 – 2018

8.2.2.6.3.2. Market Forecast, 2019 – 2027

8.2.2.6.4. Middle East and Africa

8.2.2.6.4.1. Market Estimation, 2013 – 2018

8.2.2.6.4.2. Market Forecast, 2019 – 2027

8.2.2.6.5. Latin America

8.2.2.6.5.1. Market Estimation, 2013 – 2018

8.2.2.6.5.2. Market Forecast, 2019 – 2027

8.3. Key Segment for Channeling Investments

8.3.1. By Products

9.    Global Digital Therapeutics Market Analysis and Forecasts, 2019 – 2027

9.1. Overview

9.2. Global Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Application

9.2.1. Cardiovascular Diseases

9.2.1.1.    Definition

9.2.1.2.    Market Penetration, 2018

9.2.1.3.    Market Estimation, 2013 – 2018

9.2.1.4.    Market Forecast, 2019 – 2027

9.2.1.5.    Compound Annual Growth Rate (CAGR)

9.2.1.6.    Regional Bifurcation

9.2.1.6.1. North America

9.2.1.6.1.1. Market Estimation, 2013 – 2018

9.2.1.6.1.2. Market Forecast, 2019 – 2027

9.2.1.6.2. Europe

9.2.1.6.2.1. Market Estimation, 2013 – 2018

9.2.1.6.2.2. Market Forecast, 2019 – 2027

9.2.1.6.3. Asia Pacific

9.2.1.6.3.1. Market Estimation, 2013 – 2018

9.2.1.6.3.2. Market Forecast, 2019 – 2027

9.2.1.6.4. Middle East and Africa

9.2.1.6.4.1. Market Estimation, 2013 – 2018

9.2.1.6.4.2. Market Forecast, 2019 – 2027

9.2.1.6.5. Latin America

9.2.1.6.5.1. Market Estimation, 2013 – 2018

9.2.1.6.5.2. Market Forecast, 2019 – 2027

9.2.2. Central Nervous System (CNS) Diseases

9.2.2.1.    Definition

9.2.2.2.    Market Penetration, 2018

9.2.2.3.    Market Estimation, 2013 – 2018

9.2.2.4.    Market Forecast, 2019 – 2027

9.2.2.5.    Compound Annual Growth Rate (CAGR)

9.2.2.6.    Regional Bifurcation

9.2.2.6.1. North America

9.2.2.6.1.1. Market Estimation, 2013 – 2018

9.2.2.6.1.2. Market Forecast, 2019 – 2027

9.2.2.6.2. Europe

9.2.2.6.2.1. Market Estimation, 2013 – 2018

9.2.2.6.2.2. Market Forecast, 2019 – 2027

9.2.2.6.3. Asia Pacific

9.2.2.6.3.1. Market Estimation, 2013 – 2018

9.2.2.6.3.2. Market Forecast, 2019 – 2027

9.2.2.6.4. Middle East and Africa

9.2.2.6.4.1. Market Estimation, 2013 – 2018

9.2.2.6.4.2. Market Forecast, 2019 – 2027

9.2.2.6.5. Latin America

9.2.2.6.5.1. Market Estimation, 2013 – 2018

9.2.2.6.5.2. Market Forecast, 2019 – 2027

9.2.3. Diabetes

9.2.3.1.    Definition

9.2.3.2.    Market Penetration, 2018

9.2.3.3.    Market Estimation, 2013 – 2018

9.2.3.4.    Market Forecast, 2019 – 2027

9.2.3.5.    Compound Annual Growth Rate (CAGR)

9.2.3.6.    Regional Bifurcation

9.2.3.6.1. North America

9.2.3.6.1.1. Market Estimation, 2013 – 2018

9.2.3.6.1.2. Market Forecast, 2019 – 2027

9.2.3.6.2. Europe

9.2.3.6.2.1. Market Estimation, 2013 – 2018

9.2.3.6.2.2. Market Forecast, 2019 – 2027

9.2.3.6.3. Asia Pacific

9.2.3.6.3.1. Market Estimation, 2013 – 2018

9.2.3.6.3.2. Market Forecast, 2019 – 2027

9.2.3.6.4. Middle East and Africa

9.2.3.6.4.1. Market Estimation, 2013 – 2018

9.2.3.6.4.2. Market Forecast, 2019 – 2027

9.2.3.6.5. Latin America

9.2.3.6.5.1. Market Estimation, 2013 – 2018

9.2.3.6.5.2. Market Forecast, 2019 – 2027

9.2.4. Gastrointestinal Disorders (GID)

9.2.4.1.    Definition

9.2.4.2.    Market Penetration, 2018

9.2.4.3.    Market Estimation, 2013 – 2018

9.2.4.4.    Market Forecast, 2019 – 2027

9.2.4.5.    Compound Annual Growth Rate (CAGR)

9.2.4.6.    Regional Bifurcation

9.2.4.6.1. North America

9.2.4.6.1.1. Market Estimation, 2013 – 2018

9.2.4.6.1.2. Market Forecast, 2019 – 2027

9.2.4.6.2. Europe

9.2.4.6.2.1. Market Estimation, 2013 – 2018

9.2.4.6.2.2. Market Forecast, 2019 – 2027

9.2.4.6.3. Asia Pacific

9.2.4.6.3.1. Market Estimation, 2013 – 2018

9.2.4.6.3.2. Market Forecast, 2019 – 2027

9.2.4.6.4. Middle East and Africa

9.2.4.6.4.1. Market Estimation, 2013 – 2018

9.2.4.6.4.2. Market Forecast, 2019 – 2027

9.2.4.6.5. Latin America

9.2.4.6.5.1. Market Estimation, 2013 – 2018

9.2.4.6.5.2. Market Forecast, 2019 – 2027

9.2.5. Mental Health

9.2.5.1.    Definition

9.2.5.2.    Market Penetration, 2018

9.2.5.3.    Market Estimation, 2013 – 2018

9.2.5.4.    Market Forecast, 2019 – 2027

9.2.5.5.    Compound Annual Growth Rate (CAGR)

9.2.5.6.    Regional Bifurcation

9.2.5.6.1. North America

9.2.5.6.1.1. Market Estimation, 2013 – 2018

9.2.5.6.1.2. Market Forecast, 2019 – 2027

9.2.5.6.2. Europe

9.2.5.6.2.1. Market Estimation, 2013 – 2018

9.2.5.6.2.2. Market Forecast, 2019 – 2027

9.2.5.6.3. Asia Pacific

9.2.5.6.3.1. Market Estimation, 2013 – 2018

9.2.5.6.3.2. Market Forecast, 2019 – 2027

9.2.5.6.4. Middle East and Africa

9.2.5.6.4.1. Market Estimation, 2013 – 2018

9.2.5.6.4.2. Market Forecast, 2019 – 2027

9.2.5.6.5. Latin America

9.2.5.6.5.1. Market Estimation, 2013 – 2018

9.2.5.6.5.2. Market Forecast, 2019 – 2027

9.2.6. Neurology

9.2.6.1.    Definition

9.2.6.2.    Market Penetration, 2018

9.2.6.3.    Market Estimation, 2013 – 2018

9.2.6.4.    Market Forecast, 2019 – 2027

9.2.6.5.    Compound Annual Growth Rate (CAGR)

9.2.6.6.    Regional Bifurcation

9.2.6.6.1. North America

9.2.6.6.1.1. Market Estimation, 2013 – 2018

9.2.6.6.1.2. Market Forecast, 2019 – 2027

9.2.6.6.2. Europe

9.2.6.6.2.1. Market Estimation, 2013 – 2018

9.2.6.6.2.2. Market Forecast, 2019 – 2027

9.2.6.6.3. Asia Pacific

9.2.6.6.3.1. Market Estimation, 2013 – 2018

9.2.6.6.3.2. Market Forecast, 2019 – 2027

9.2.6.6.4. Middle East and Africa

9.2.6.6.4.1. Market Estimation, 2013 – 2018

9.2.6.6.4.2. Market Forecast, 2019 – 2027

9.2.6.6.5. Latin America

9.2.6.6.5.1. Market Estimation, 2013 – 2018

9.2.6.6.5.2. Market Forecast, 2019 – 2027

9.2.7. Obesity

9.2.7.1.    Definition

9.2.7.2.    Market Penetration, 2018

9.2.7.3.    Market Estimation, 2013 – 2018

9.2.7.4.    Market Forecast, 2019 – 2027

9.2.7.5.    Compound Annual Growth Rate (CAGR)

9.2.7.6.    Regional Bifurcation

9.2.7.6.1. North America

9.2.7.6.1.1. Market Estimation, 2013 – 2018

9.2.7.6.1.2. Market Forecast, 2019 – 2027

9.2.7.6.2. Europe

9.2.7.6.2.1. Market Estimation, 2013 – 2018

9.2.7.6.2.2. Market Forecast, 2019 – 2027

9.2.7.6.3. Asia Pacific

9.2.7.6.3.1. Market Estimation, 2013 – 2018

9.2.7.6.3.2. Market Forecast, 2019 – 2027

9.2.7.6.4. Middle East and Africa

9.2.7.6.4.1. Market Estimation, 2013 – 2018

9.2.7.6.4.2. Market Forecast, 2019 – 2027

9.2.7.6.5. Latin America

9.2.7.6.5.1. Market Estimation, 2013 – 2018

9.2.7.6.5.2. Market Forecast, 2019 – 2027

9.2.8. Ophthalmology

9.2.8.1.    Definition

9.2.8.2.    Market Penetration, 2018

9.2.8.3.    Market Estimation, 2013 – 2018

9.2.8.4.    Market Forecast, 2019 – 2027

9.2.8.5.    Compound Annual Growth Rate (CAGR)

9.2.8.6.    Regional Bifurcation

9.2.8.6.1. North America

9.2.8.6.1.1. Market Estimation, 2013 – 2018

9.2.8.6.1.2. Market Forecast, 2019 – 2027

9.2.8.6.2. Europe

9.2.8.6.2.1. Market Estimation, 2013 – 2018

9.2.8.6.2.2. Market Forecast, 2019 – 2027

9.2.8.6.3. Asia Pacific

9.2.8.6.3.1. Market Estimation, 2013 – 2018

9.2.8.6.3.2. Market Forecast, 2019 – 2027

9.2.8.6.4. Middle East and Africa

9.2.8.6.4.1. Market Estimation, 2013 – 2018

9.2.8.6.4.2. Market Forecast, 2019 – 2027

9.2.8.6.5. Latin America

9.2.8.6.5.1. Market Estimation, 2013 – 2018

9.2.8.6.5.2. Market Forecast, 2019 – 2027

9.2.9. Respiratory Diseases

9.2.9.1.    Definition

9.2.9.2.    Market Penetration, 2018

9.2.9.3.    Market Estimation, 2013 – 2018

9.2.9.4.    Market Forecast, 2019 – 2027

9.2.9.5.    Compound Annual Growth Rate (CAGR)

9.2.9.6.    Regional Bifurcation

9.2.9.6.1. North America

9.2.9.6.1.1. Market Estimation, 2013 – 2018

9.2.9.6.1.2. Market Forecast, 2019 – 2027

9.2.9.6.2. Europe

9.2.9.6.2.1. Market Estimation, 2013 – 2018

9.2.9.6.2.2. Market Forecast, 2019 – 2027

9.2.9.6.3. Asia Pacific

9.2.9.6.3.1. Market Estimation, 2013 – 2018

9.2.9.6.3.2. Market Forecast, 2019 – 2027

9.2.9.6.4. Middle East and Africa

9.2.9.6.4.1. Market Estimation, 2013 – 2018

9.2.9.6.4.2. Market Forecast, 2019 – 2027

9.2.9.6.5. Latin America

9.2.9.6.5.1. Market Estimation, 2013 – 2018

9.2.9.6.5.2. Market Forecast, 2019 – 2027

9.2.10. Smoking Cessation

9.2.10.1.  Definition

9.2.10.2.  Market Penetration, 2018

9.2.10.3.  Market Estimation, 2013 – 2018

9.2.10.4.  Market Forecast, 2019 – 2027

9.2.10.5.  Compound Annual Growth Rate (CAGR)

9.2.10.6.  Regional Bifurcation

9.2.10.6.1. North America

9.2.10.6.1.1. Market Estimation, 2013 – 2018

9.2.10.6.1.2. Market Forecast, 2019 – 2027

9.2.10.6.2. Europe

9.2.10.6.2.1. Market Estimation, 2013 – 2018

9.2.10.6.2.2. Market Forecast, 2019 – 2027

9.2.10.6.3. Asia Pacific

9.2.10.6.3.1. Market Estimation, 2013 – 2018

9.2.10.6.3.2. Market Forecast, 2019 – 2027

9.2.10.6.4. Middle East and Africa

9.2.10.6.4.1. Market Estimation, 2013 – 2018

9.2.10.6.4.2. Market Forecast, 2019 – 2027

9.2.10.6.5. Latin America

9.2.10.6.5.1. Market Estimation, 2013 – 2018

9.2.10.6.5.2. Market Forecast, 2019 – 2027

9.2.11. Others

9.2.11.1.  Definition

9.2.11.2.  Market Penetration, 2018

9.2.11.3.  Market Estimation, 2013 – 2018

9.2.11.4.  Market Forecast, 2019 – 2027

9.2.11.5.  Compound Annual Growth Rate (CAGR)

9.2.11.6.  Regional Bifurcation

9.2.11.6.1. North America

9.2.11.6.1.1. Market Estimation, 2013 – 2018

9.2.11.6.1.2. Market Forecast, 2019 – 2027

9.2.11.6.2. Europe

9.2.11.6.2.1. Market Estimation, 2013 – 2018

9.2.11.6.2.2. Market Forecast, 2019 – 2027

9.2.11.6.3. Asia Pacific

9.2.11.6.3.1. Market Estimation, 2013 – 2018

9.2.11.6.3.2. Market Forecast, 2019 – 2027

9.2.11.6.4. Middle East and Africa

9.2.11.6.4.1. Market Estimation, 2013 – 2018

9.2.11.6.4.2. Market Forecast, 2019 – 2027

9.2.11.6.5. Latin America

9.2.11.6.5.1. Market Estimation, 2013 – 2018

9.2.11.6.5.2. Market Forecast, 2019 – 2027

9.3. Key Segment for Channeling Investments

9.3.1. By Application

10. Global Digital Therapeutics Market Analysis and Forecasts, 2019 – 2027

10.1. Overview

10.2. Global Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

10.2.1. Business to Business

10.2.1.1.  Definition

10.2.1.2.  Market Penetration, 2018

10.2.1.3.  Market Estimation, 2013 – 2018

10.2.1.4.  Market Forecast, 2019 – 2027

10.2.1.5.  Compound Annual Growth Rate (CAGR)

10.2.1.6.  Regional Bifurcation

10.2.1.6.1. North America

10.2.1.6.1.1. Market Estimation, 2013 – 2018

10.2.1.6.1.2. Market Forecast, 2019 – 2027

10.2.1.6.2. Europe

10.2.1.6.2.1. Market Estimation, 2013 – 2018

10.2.1.6.2.2. Market Forecast, 2019 – 2027

10.2.1.6.3. Asia Pacific

10.2.1.6.3.1. Market Estimation, 2013 – 2018

10.2.1.6.3.2. Market Forecast, 2019 – 2027

10.2.1.6.4. Middle East and Africa

10.2.1.6.4.1. Market Estimation, 2013 – 2018

10.2.1.6.4.2. Market Forecast, 2019 – 2027

10.2.1.6.5. Latin America

10.2.1.6.5.1. Market Estimation, 2013 – 2018

10.2.1.6.5.2. Market Forecast, 2019 – 2027

10.2.2. Business to Customer

10.2.2.1.  Definition

10.2.2.2.  Market Penetration, 2018

10.2.2.3.  Market Estimation, 2013 – 2018

10.2.2.4.  Market Forecast, 2019 – 2027

10.2.2.5.  Compound Annual Growth Rate (CAGR)

10.2.2.6.  Regional Bifurcation

10.2.2.6.1. North America

10.2.2.6.1.1. Market Estimation, 2013 – 2018

10.2.2.6.1.2. Market Forecast, 2019 – 2027

10.2.2.6.2. Europe

10.2.2.6.2.1. Market Estimation, 2013 – 2018

10.2.2.6.2.2. Market Forecast, 2019 – 2027

10.2.2.6.3. Asia Pacific

10.2.2.6.3.1. Market Estimation, 2013 – 2018

10.2.2.6.3.2. Market Forecast, 2019 – 2027

10.2.2.6.4. Middle East and Africa

10.2.2.6.4.1. Market Estimation, 2013 – 2018

10.2.2.6.4.2. Market Forecast, 2019 – 2027

10.2.2.6.5. Latin America

10.2.2.6.5.1. Market Estimation, 2013 – 2018

10.2.2.6.5.2. Market Forecast, 2019 – 2027

10.3. Key Segment for Channeling Investments

10.3.1. By Distribution Channel

11. Global Digital Therapeutics Market Analysis and Forecasts, 2019 – 2027

11.1. Overview

11.2. Global Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By End User

11.2.1. Patients

11.2.1.1.  Definition

11.2.1.2.  Market Penetration, 2018

11.2.1.3.  Market Estimation, 2013 – 2018

11.2.1.4.  Market Forecast, 2019 – 2027

11.2.1.5.  Compound Annual Growth Rate (CAGR)

11.2.1.6.  Regional Bifurcation

11.2.1.6.1. North America

11.2.1.6.1.1. Market Estimation, 2013 – 2018

11.2.1.6.1.2. Market Forecast, 2019 – 2027

11.2.1.6.2. Europe

11.2.1.6.2.1. Market Estimation, 2013 – 2018

11.2.1.6.2.2. Market Forecast, 2019 – 2027

11.2.1.6.3. Asia Pacific

11.2.1.6.3.1. Market Estimation, 2013 – 2018

11.2.1.6.3.2. Market Forecast, 2019 – 2027

11.2.1.6.4. Middle East and Africa

11.2.1.6.4.1. Market Estimation, 2013 – 2018

11.2.1.6.4.2. Market Forecast, 2019 – 2027

11.2.1.6.5. Latin America

11.2.1.6.5.1. Market Estimation, 2013 – 2018

11.2.1.6.5.2. Market Forecast, 2019 – 2027

11.2.2. Healthcare Providers

11.2.2.1.  Definition

11.2.2.2.  Market Penetration, 2018

11.2.2.3.  Market Estimation, 2013 – 2018

11.2.2.4.  Market Forecast, 2019 – 2027

11.2.2.5.  Compound Annual Growth Rate (CAGR)

11.2.2.6.  Regional Bifurcation

11.2.2.6.1. North America

11.2.2.6.1.1. Market Estimation, 2013 – 2018

11.2.2.6.1.2. Market Forecast, 2019 – 2027

11.2.2.6.2. Europe

11.2.2.6.2.1. Market Estimation, 2013 – 2018

11.2.2.6.2.2. Market Forecast, 2019 – 2027

11.2.2.6.3. Asia Pacific

11.2.2.6.3.1. Market Estimation, 2013 – 2018

11.2.2.6.3.2. Market Forecast, 2019 – 2027

11.2.2.6.4. Middle East and Africa

11.2.2.6.4.1. Market Estimation, 2013 – 2018

11.2.2.6.4.2. Market Forecast, 2019 – 2027

11.2.2.6.5. Latin America

11.2.2.6.5.1. Market Estimation, 2013 – 2018

11.2.2.6.5.2. Market Forecast, 2019 – 2027

11.2.3. Payers

11.2.3.1.  Definition

11.2.3.2.  Market Penetration, 2018

11.2.3.3.  Market Estimation, 2013 – 2018

11.2.3.4.  Market Forecast, 2019 – 2027

11.2.3.5.  Compound Annual Growth Rate (CAGR)

11.2.3.6.  Regional Bifurcation

11.2.3.6.1. North America

11.2.3.6.1.1. Market Estimation, 2013 – 2018

11.2.3.6.1.2. Market Forecast, 2019 – 2027

11.2.3.6.2. Europe

11.2.3.6.2.1. Market Estimation, 2013 – 2018

11.2.3.6.2.2. Market Forecast, 2019 – 2027

11.2.3.6.3. Asia Pacific

11.2.3.6.3.1. Market Estimation, 2013 – 2018

11.2.3.6.3.2. Market Forecast, 2019 – 2027

11.2.3.6.4. Middle East and Africa

11.2.3.6.4.1. Market Estimation, 2013 – 2018

11.2.3.6.4.2. Market Forecast, 2019 – 2027

11.2.3.6.5. Latin America

11.2.3.6.5.1. Market Estimation, 2013 – 2018

11.2.3.6.5.2. Market Forecast, 2019 – 2027

11.2.4. Employers

11.2.4.1.  Definition

11.2.4.2.  Market Penetration, 2018

11.2.4.3.  Market Estimation, 2013 – 2018

11.2.4.4.  Market Forecast, 2019 – 2027

11.2.4.5.  Compound Annual Growth Rate (CAGR)

11.2.4.6.  Regional Bifurcation

11.2.4.6.1. North America

11.2.4.6.1.1. Market Estimation, 2013 – 2018

11.2.4.6.1.2. Market Forecast, 2019 – 2027

11.2.4.6.2. Europe

11.2.4.6.2.1. Market Estimation, 2013 – 2018

11.2.4.6.2.2. Market Forecast, 2019 – 2027

11.2.4.6.3. Asia Pacific

11.2.4.6.3.1. Market Estimation, 2013 – 2018

11.2.4.6.3.2. Market Forecast, 2019 – 2027

11.2.4.6.4. Middle East and Africa

11.2.4.6.4.1. Market Estimation, 2013 – 2018

11.2.4.6.4.2. Market Forecast, 2019 – 2027

11.2.4.6.5. Latin America

11.2.4.6.5.1. Market Estimation, 2013 – 2018

11.2.4.6.5.2. Market Forecast, 2019 – 2027

11.2.5. Other (Fitness and Wellness Centers, Gym, Etc.)

11.2.5.1.  Definition

11.2.5.2.  Market Penetration, 2018

11.2.5.3.  Market Estimation, 2013 – 2018

11.2.5.4.  Market Forecast, 2019 – 2027

11.2.5.5.  Compound Annual Growth Rate (CAGR)

11.2.5.6.  Regional Bifurcation

11.2.5.6.1. North America

11.2.5.6.1.1. Market Estimation, 2013 – 2018

11.2.5.6.1.2. Market Forecast, 2019 – 2027

11.2.5.6.2. Europe

11.2.5.6.2.1. Market Estimation, 2013 – 2018

11.2.5.6.2.2. Market Forecast, 2019 – 2027

11.2.5.6.3. Asia Pacific

11.2.5.6.3.1. Market Estimation, 2013 – 2018

11.2.5.6.3.2. Market Forecast, 2019 – 2027

11.2.5.6.4. Middle East and Africa

11.2.5.6.4.1. Market Estimation, 2013 – 2018

11.2.5.6.4.2. Market Forecast, 2019 – 2027

11.2.5.6.5. Latin America

11.2.5.6.5.1. Market Estimation, 2013 – 2018

11.2.5.6.5.2. Market Forecast, 2019 – 2027

11.3. Key Segment for Channeling Investments

11.3.1. By End User

12. North America Digital Therapeutics Market Analysis and Forecasts, 2019 - 2027

12.1. Overview

12.1.1. North America Digital Therapeutics Market Revenue (US$ Mn)

12.2. North America Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Products

12.2.1. Software

12.2.2. Devices

12.3. North America Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Application

12.3.1. Cardiovascular Diseases

12.3.2. Central Nervous System (CNS) Diseases

12.3.3. Diabetes

12.3.4. Gastrointestinal Disorders (GID)

12.3.5. Mental Health

12.3.6. Neurology

12.3.7. Obesity

12.3.8. Ophthalmology

12.3.9. Respiratory Diseases

12.3.10. Smoking Cessation

12.3.11. Others

12.4. North America Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

12.4.1. Business to Business

12.4.2. Business to Customer

12.5. North America Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By End User

12.5.1. Patients

12.5.2. Healthcare Providers

12.5.3. Payers

12.5.4. Employers

12.5.5. Other (Fitness and Wellness Centers, Gym, Etc.)

12.6. North America Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Country

12.6.1. U.S

12.6.1.1.  U.S Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Products

12.6.1.1.1. Software

12.6.1.1.2. Devices

12.6.1.2.  U.S Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Application

12.6.1.2.1. Cardiovascular Diseases

12.6.1.2.2. Central Nervous System (CNS) Diseases

12.6.1.2.3. Diabetes

12.6.1.2.4. Gastrointestinal Disorders (GID)

12.6.1.2.5. Mental Health

12.6.1.2.6. Neurology

12.6.1.2.7. Obesity

12.6.1.2.8. Ophthalmology

12.6.1.2.9. Respiratory Diseases

12.6.1.2.10. Smoking Cessation

12.6.1.2.11. Others

12.6.1.3.  U.S Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

12.6.1.3.1. Business to Business

12.6.1.3.2. Business to Customer

12.6.1.4.  U.S Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By End User

12.6.1.4.1. Patients

12.6.1.4.2. Healthcare Providers

12.6.1.4.3. Payers

12.6.1.4.4. Employers

12.6.1.4.5. Other (Fitness and Wellness Centers, Gym, Etc.)

12.6.2. Canada

12.6.2.1.  Canada Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Products

12.6.2.1.1. Software

12.6.2.1.2. Devices

12.6.2.2.  Canada Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Application

12.6.2.2.1. Cardiovascular Diseases

12.6.2.2.2. Central Nervous System (CNS) Diseases

12.6.2.2.3. Diabetes

12.6.2.2.4. Gastrointestinal Disorders (GID)

12.6.2.2.5. Mental Health

12.6.2.2.6. Neurology

12.6.2.2.7. Obesity

12.6.2.2.8. Ophthalmology

12.6.2.2.9. Respiratory Diseases

12.6.2.2.10. Smoking Cessation

12.6.2.2.11. Others

12.6.2.3.  Canada Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

12.6.2.3.1. Business to Business

12.6.2.3.2. Business to Customer

12.6.2.4.  Canada Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By End User

12.6.2.4.1. Patients

12.6.2.4.2. Healthcare Providers

12.6.2.4.3. Payers

12.6.2.4.4. Employers

12.6.2.4.5. Other (Fitness and Wellness Centers, Gym, Etc.)

12.6.3. Mexico

12.6.3.1.  Mexico Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Products

12.6.3.1.1. Software

12.6.3.1.2. Devices

12.6.3.2.  Mexico Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Application

12.6.3.2.1. Cardiovascular Diseases

12.6.3.2.2. Central Nervous System (CNS) Diseases

12.6.3.2.3. Diabetes

12.6.3.2.4. Gastrointestinal Disorders (GID)

12.6.3.2.5. Mental Health

12.6.3.2.6. Neurology

12.6.3.2.7. Obesity

12.6.3.2.8. Ophthalmology

12.6.3.2.9. Respiratory Diseases

12.6.3.2.10. Smoking Cessation

12.6.3.2.11. Others

12.6.3.3.  Mexico Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

12.6.3.3.1. Business to Business

12.6.3.3.2. Business to Customer

12.6.3.4.  Mexico Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By End User

12.6.3.4.1. Patients

12.6.3.4.2. Healthcare Providers

12.6.3.4.3. Payers

12.6.3.4.4. Employers

12.6.3.4.5. Other (Fitness and Wellness Centers, Gym, Etc.)

12.6.4. Rest of North America

12.6.4.1.  Rest of North America Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Products

12.6.4.1.1. Software

12.6.4.1.2. Devices

12.6.4.2.  Rest of North America Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Application

12.6.4.2.1. Cardiovascular Diseases

12.6.4.2.2. Central Nervous System (CNS) Diseases

12.6.4.2.3. Diabetes

12.6.4.2.4. Gastrointestinal Disorders (GID)

12.6.4.2.5. Mental Health

12.6.4.2.6. Neurology

12.6.4.2.7. Obesity

12.6.4.2.8. Ophthalmology

12.6.4.2.9. Respiratory Diseases

12.6.4.2.10. Smoking Cessation

12.6.4.2.11. Others

12.6.4.3.  Rest of North America Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

12.6.4.3.1. Business to Business

12.6.4.3.2. Business to Customer

12.6.4.4.  Rest of North America Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By End User

12.6.4.4.1. Patients

12.6.4.4.2. Healthcare Providers

12.6.4.4.3. Payers

12.6.4.4.4. Employers

12.6.4.4.5. Other (Fitness and Wellness Centers, Gym, Etc.)

12.7. Key Segment for Channeling Investments

12.7.1. By Country

12.7.2. By Products

12.7.3. By Application

12.7.4. By Distribution Channel

12.7.5. By End User

13. Europe Digital Therapeutics Market Analysis and Forecasts, 2019 - 2027

13.1. Overview

13.1.1. Europe Digital Therapeutics Market Revenue (US$ Mn)

13.2. Europe Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Products

13.2.1. Software

13.2.2. Devices

13.3. Europe Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Application

13.3.1. Cardiovascular Diseases

13.3.2. Central Nervous System (CNS) Diseases

13.3.3. Diabetes

13.3.4. Gastrointestinal Disorders (GID)

13.3.5. Mental Health

13.3.6. Neurology

13.3.7. Obesity

13.3.8. Ophthalmology

13.3.9. Respiratory Diseases

13.3.10. Smoking Cessation

13.3.11. Others

13.4. Europe Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

13.4.1. Business to Business

13.4.2. Business to Customer

13.5. Europe Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By End User

13.5.1. Patients

13.5.2. Healthcare Providers

13.5.3. Payers

13.5.4. Employers

13.5.5. Other (Fitness and Wellness Centers, Gym, Etc.)

13.6. Europe Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Country

13.6.1. France

13.6.1.1.  France Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Products

13.6.1.1.1. Software

13.6.1.1.2. Devices

13.6.1.2.  France Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Application

13.6.1.2.1. Cardiovascular Diseases

13.6.1.2.2. Central Nervous System (CNS) Diseases

13.6.1.2.3. Diabetes

13.6.1.2.4. Gastrointestinal Disorders (GID)

13.6.1.2.5. Mental Health

13.6.1.2.6. Neurology

13.6.1.2.7. Obesity

13.6.1.2.8. Ophthalmology

13.6.1.2.9. Respiratory Diseases

13.6.1.2.10. Smoking Cessation

13.6.1.2.11. Others

13.6.1.3.  France Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

13.6.1.3.1. Business to Business

13.6.1.3.2. Business to Customer

13.6.1.4.  France Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By End User

13.6.1.4.1. Patients

13.6.1.4.2. Healthcare Providers

13.6.1.4.3. Payers

13.6.1.4.4. Employers

13.6.1.4.5. Other (Fitness and Wellness Centers, Gym, Etc.)

13.6.2. The UK

13.6.2.1.  The UK Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Products

13.6.2.1.1. Software

13.6.2.1.2. Devices

13.6.2.2.  The UK Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Application

13.6.2.2.1. Cardiovascular Diseases

13.6.2.2.2. Central Nervous System (CNS) Diseases

13.6.2.2.3. Diabetes

13.6.2.2.4. Gastrointestinal Disorders (GID)

13.6.2.2.5. Mental Health

13.6.2.2.6. Neurology

13.6.2.2.7. Obesity

13.6.2.2.8. Ophthalmology

13.6.2.2.9. Respiratory Diseases

13.6.2.2.10. Smoking Cessation

13.6.2.2.11. Others

13.6.2.3.  The UK Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

13.6.2.3.1. Business to Business

13.6.2.3.2. Business to Customer

13.6.2.4.  The UK Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By End User

13.6.2.4.1. Patients

13.6.2.4.2. Healthcare Providers

13.6.2.4.3. Payers

13.6.2.4.4. Employers

13.6.2.4.5. Other (Fitness and Wellness Centers, Gym, Etc.)

13.6.3. Spain

13.6.3.1.  Spain Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Products

13.6.3.1.1. Software

13.6.3.1.2. Devices

13.6.3.2.  Spain Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Application

13.6.3.2.1. Cardiovascular Diseases

13.6.3.2.2. Central Nervous System (CNS) Diseases

13.6.3.2.3. Diabetes

13.6.3.2.4. Gastrointestinal Disorders (GID)

13.6.3.2.5. Mental Health

13.6.3.2.6. Neurology

13.6.3.2.7. Obesity

13.6.3.2.8. Ophthalmology

13.6.3.2.9. Respiratory Diseases

13.6.3.2.10. Smoking Cessation

13.6.3.2.11. Others

13.6.3.3.  Spain Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

13.6.3.3.1. Business to Business

13.6.3.3.2. Business to Customer

13.6.3.4.  Spain Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By End User

13.6.3.4.1. Patients

13.6.3.4.2. Healthcare Providers

13.6.3.4.3. Payers

13.6.3.4.4. Employers

13.6.3.4.5. Other (Fitness and Wellness Centers, Gym, Etc.)

13.6.4. Germany

13.6.4.1.  Germany Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Products

13.6.4.1.1. Software

13.6.4.1.2. Devices

13.6.4.2.  Germany Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Application

13.6.4.2.1. Cardiovascular Diseases

13.6.4.2.2. Central Nervous System (CNS) Diseases

13.6.4.2.3. Diabetes

13.6.4.2.4. Gastrointestinal Disorders (GID)

13.6.4.2.5. Mental Health

13.6.4.2.6. Neurology

13.6.4.2.7. Obesity

13.6.4.2.8. Ophthalmology

13.6.4.2.9. Respiratory Diseases

13.6.4.2.10. Smoking Cessation

13.6.4.2.11. Others

13.6.4.3.  Germany Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

13.6.4.3.1. Business to Business

13.6.4.3.2. Business to Customer

13.6.4.4.  Germany Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By End User

13.6.4.4.1. Patients

13.6.4.4.2. Healthcare Providers

13.6.4.4.3. Payers

13.6.4.4.4. Employers

13.6.4.4.5. Other (Fitness and Wellness Centers, Gym, Etc.)

13.6.5. Italy

13.6.5.1.  Italy Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Products

13.6.5.1.1. Software

13.6.5.1.2. Devices

13.6.5.2.  Italy Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Application

13.6.5.2.1. Cardiovascular Diseases

13.6.5.2.2. Central Nervous System (CNS) Diseases

13.6.5.2.3. Diabetes

13.6.5.2.4. Gastrointestinal Disorders (GID)

13.6.5.2.5. Mental Health

13.6.5.2.6. Neurology

13.6.5.2.7. Obesity

13.6.5.2.8. Ophthalmology

13.6.5.2.9. Respiratory Diseases

13.6.5.2.10. Smoking Cessation

13.6.5.2.11. Others

13.6.5.3.  Italy Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

13.6.5.3.1. Business to Business

13.6.5.3.2. Business to Customer

13.6.5.4.  Italy Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By End User

13.6.5.4.1. Patients

13.6.5.4.2. Healthcare Providers

13.6.5.4.3. Payers

13.6.5.4.4. Employers

13.6.5.4.5. Other (Fitness and Wellness Centers, Gym, Etc.)

13.6.6. Nordic Countries

13.6.6.1.  Nordic Countries Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Products

13.6.6.1.1. Software

13.6.6.1.2. Devices

13.6.6.2.  Nordic Countries Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Application

13.6.6.2.1. Cardiovascular Diseases

13.6.6.2.2. Central Nervous System (CNS) Diseases

13.6.6.2.3. Diabetes

13.6.6.2.4. Gastrointestinal Disorders (GID)

13.6.6.2.5. Mental Health

13.6.6.2.6. Neurology

13.6.6.2.7. Obesity

13.6.6.2.8. Ophthalmology

13.6.6.2.9. Respiratory Diseases

13.6.6.2.10. Smoking Cessation

13.6.6.2.11. Others

13.6.6.3.  Nordic Countries Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

13.6.6.3.1. Business to Business

13.6.6.3.2. Business to Customer

13.6.6.4.  Nordic Countries Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By End User

13.6.6.4.1. Patients

13.6.6.4.2. Healthcare Providers

13.6.6.4.3. Payers

13.6.6.4.4. Employers

13.6.6.4.5. Other (Fitness and Wellness Centers, Gym, Etc.)

13.6.6.5.  Nordic Countries Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Country

13.6.6.5.1. Denmark

13.6.6.5.2. Finland

13.6.6.5.3. Iceland

13.6.6.5.4. Sweden

13.6.6.5.5. Norway

13.6.7. Benelux Union

13.6.7.1.  Benelux Union Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Products

13.6.7.1.1. Software

13.6.7.1.2. Devices

13.6.7.2.  Benelux Union Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Application

13.6.7.2.1. Cardiovascular Diseases

13.6.7.2.2. Central Nervous System (CNS) Diseases

13.6.7.2.3. Diabetes

13.6.7.2.4. Gastrointestinal Disorders (GID)

13.6.7.2.5. Mental Health

13.6.7.2.6. Neurology

13.6.7.2.7. Obesity

13.6.7.2.8. Ophthalmology

13.6.7.2.9. Respiratory Diseases

13.6.7.2.10. Smoking Cessation

13.6.7.2.11. Others

13.6.7.3.  Benelux Union Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

13.6.7.3.1. Business to Business

13.6.7.3.2. Business to Customer

13.6.7.4.  Benelux Union Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By End User

13.6.7.4.1. Patients

13.6.7.4.2. Healthcare Providers

13.6.7.4.3. Payers

13.6.7.4.4. Employers

13.6.7.4.5. Other (Fitness and Wellness Centers, Gym, Etc.)

13.6.7.5.  Benelux Union Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Country

13.6.7.5.1. Belgium

13.6.7.5.2. The Netherlands

13.6.7.5.3. Luxembourg

13.6.8. Rest of Europe

13.6.8.1.  Rest of Europe Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Products

13.6.8.1.1. Software

13.6.8.1.2. Devices

13.6.8.2.  Rest of Europe Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Application

13.6.8.2.1. Cardiovascular Diseases

13.6.8.2.2. Central Nervous System (CNS) Diseases

13.6.8.2.3. Diabetes

13.6.8.2.4. Gastrointestinal Disorders (GID)

13.6.8.2.5. Mental Health

13.6.8.2.6. Neurology

13.6.8.2.7. Obesity

13.6.8.2.8. Ophthalmology

13.6.8.2.9. Respiratory Diseases

13.6.8.2.10. Smoking Cessation

13.6.8.2.11. Others

13.6.8.3.  Rest of Europe Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

13.6.8.3.1. Business to Business

13.6.8.3.2. Business to Customer

13.6.8.4.  Rest of Europe Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By End User

13.6.8.4.1. Patients

13.6.8.4.2. Healthcare Providers

13.6.8.4.3. Payers

13.6.8.4.4. Employers

13.6.8.4.5. Other (Fitness and Wellness Centers, Gym, Etc.)

13.7. Key Segment for Channeling Investments

13.7.1. By Country

13.7.2. By Products

13.7.3. By Application

13.7.4. By Distribution Channel

13.7.5. By End User

14. Asia Pacific Digital Therapeutics Market Analysis and Forecasts, 2019 - 2027

14.1. Overview

14.1.1. Asia Pacific Digital Therapeutics Market Revenue (US$ Mn)

14.2. Asia Pacific Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Products

14.2.1. Software

14.2.2. Devices

14.3. Asia Pacific Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Application

14.3.1. Cardiovascular Diseases

14.3.2. Central Nervous System (CNS) Diseases

14.3.3. Diabetes

14.3.4. Gastrointestinal Disorders (GID)

14.3.5. Mental Health

14.3.6. Neurology

14.3.7. Obesity

14.3.8. Ophthalmology

14.3.9. Respiratory Diseases

14.3.10. Smoking Cessation

14.3.11. Others

14.4. Asia Pacific Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

14.4.1. Business to Business

14.4.2. Business to Customer

14.5. Asia Pacific Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By End User

14.5.1. Patients

14.5.2. Healthcare Providers

14.5.3. Payers

14.5.4. Employers

14.5.5. Other (Fitness and Wellness Centers, Gym, Etc.)

14.6. Asia Pacific Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Country

14.6.1. China

14.6.1.1.  China Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Products

14.6.1.1.1. Software

14.6.1.1.2. Devices

14.6.1.2.  China Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Application

14.6.1.2.1. Cardiovascular Diseases

14.6.1.2.2. Central Nervous System (CNS) Diseases

14.6.1.2.3. Diabetes

14.6.1.2.4. Gastrointestinal Disorders (GID)

14.6.1.2.5. Mental Health

14.6.1.2.6. Neurology

14.6.1.2.7. Obesity

14.6.1.2.8. Ophthalmology

14.6.1.2.9. Respiratory Diseases

14.6.1.2.10. Smoking Cessation

14.6.1.2.11. Others

14.6.1.3.  China Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

14.6.1.3.1. Business to Business

14.6.1.3.2. Business to Customer

14.6.1.4.  China Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By End User

14.6.1.4.1. Patients

14.6.1.4.2. Healthcare Providers

14.6.1.4.3. Payers

14.6.1.4.4. Employers

14.6.1.4.5. Other (Fitness and Wellness Centers, Gym, Etc.)

14.6.2. Japan

14.6.2.1.  Japan Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Products

14.6.2.1.1. Software

14.6.2.1.2. Devices

14.6.2.2.  Japan Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Application

14.6.2.2.1. Cardiovascular Diseases

14.6.2.2.2. Central Nervous System (CNS) Diseases

14.6.2.2.3. Diabetes

14.6.2.2.4. Gastrointestinal Disorders (GID)

14.6.2.2.5. Mental Health

14.6.2.2.6. Neurology

14.6.2.2.7. Obesity

14.6.2.2.8. Ophthalmology

14.6.2.2.9. Respiratory Diseases

14.6.2.2.10. Smoking Cessation

14.6.2.2.11. Others

14.6.2.3.  Japan Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

14.6.2.3.1. Business to Business

14.6.2.3.2. Business to Customer

14.6.2.4.  Japan Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By End User

14.6.2.4.1. Patients

14.6.2.4.2. Healthcare Providers

14.6.2.4.3. Payers

14.6.2.4.4. Employers

14.6.2.4.5. Other (Fitness and Wellness Centers, Gym, Etc.)

14.6.3. India

14.6.3.1.  India Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Products

14.6.3.1.1. Software

14.6.3.1.2. Devices

14.6.3.2.  India Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Application

14.6.3.2.1. Cardiovascular Diseases

14.6.3.2.2. Central Nervous System (CNS) Diseases

14.6.3.2.3. Diabetes

14.6.3.2.4. Gastrointestinal Disorders (GID)

14.6.3.2.5. Mental Health

14.6.3.2.6. Neurology

14.6.3.2.7. Obesity

14.6.3.2.8. Ophthalmology

14.6.3.2.9. Respiratory Diseases

14.6.3.2.10. Smoking Cessation

14.6.3.2.11. Others

14.6.3.3.  India Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

14.6.3.3.1. Business to Business

14.6.3.3.2. Business to Customer

14.6.3.4.  India Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By End User

14.6.3.4.1. Patients

14.6.3.4.2. Healthcare Providers

14.6.3.4.3. Payers

14.6.3.4.4. Employers

14.6.3.4.5. Other (Fitness and Wellness Centers, Gym, Etc.)

14.6.4. New Zealand

14.6.4.1.  New Zealand Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Products

14.6.4.1.1. Software

14.6.4.1.2. Devices

14.6.4.2.  New Zealand Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Application

14.6.4.2.1. Cardiovascular Diseases

14.6.4.2.2. Central Nervous System (CNS) Diseases

14.6.4.2.3. Diabetes

14.6.4.2.4. Gastrointestinal Disorders (GID)

14.6.4.2.5. Mental Health

14.6.4.2.6. Neurology

14.6.4.2.7. Obesity

14.6.4.2.8. Ophthalmology

14.6.4.2.9. Respiratory Diseases

14.6.4.2.10. Smoking Cessation

14.6.4.2.11. Others

14.6.4.3.  New Zealand Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

14.6.4.3.1. Business to Business

14.6.4.3.2. Business to Customer

14.6.4.4.  New Zealand Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By End User

14.6.4.4.1. Patients

14.6.4.4.2. Healthcare Providers

14.6.4.4.3. Payers

14.6.4.4.4. Employers

14.6.4.4.5. Other (Fitness and Wellness Centers, Gym, Etc.)

14.6.5. Australia

14.6.5.1.  Australia Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Products

14.6.5.1.1. Software

14.6.5.1.2. Devices

14.6.5.2.  Australia Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Application

14.6.5.2.1. Cardiovascular Diseases

14.6.5.2.2. Central Nervous System (CNS) Diseases

14.6.5.2.3. Diabetes

14.6.5.2.4. Gastrointestinal Disorders (GID)

14.6.5.2.5. Mental Health

14.6.5.2.6. Neurology

14.6.5.2.7. Obesity

14.6.5.2.8. Ophthalmology

14.6.5.2.9. Respiratory Diseases

14.6.5.2.10. Smoking Cessation

14.6.5.2.11. Others

14.6.5.3.  Australia Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

14.6.5.3.1. Business to Business

14.6.5.3.2. Business to Customer

14.6.5.4.  Australia Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By End User

14.6.5.4.1. Patients

14.6.5.4.2. Healthcare Providers

14.6.5.4.3. Payers

14.6.5.4.4. Employers

14.6.5.4.5. Other (Fitness and Wellness Centers, Gym, Etc.)

14.6.6. South Korea

14.6.6.1.  South Korea Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Products

14.6.6.1.1. Software

14.6.6.1.2. Devices

14.6.6.2.  South Korea Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Application

14.6.6.2.1. Cardiovascular Diseases

14.6.6.2.2. Central Nervous System (CNS) Diseases

14.6.6.2.3. Diabetes

14.6.6.2.4. Gastrointestinal Disorders (GID)

14.6.6.2.5. Mental Health

14.6.6.2.6. Neurology

14.6.6.2.7. Obesity

14.6.6.2.8. Ophthalmology

14.6.6.2.9. Respiratory Diseases

14.6.6.2.10. Smoking Cessation

14.6.6.2.11. Others

14.6.6.3.  South Korea Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

14.6.6.3.1. Business to Business

14.6.6.3.2. Business to Customer

14.6.6.4.  South Korea Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By End User

14.6.6.4.1. Patients

14.6.6.4.2. Healthcare Providers

14.6.6.4.3. Payers

14.6.6.4.4. Employers

14.6.6.4.5. Other (Fitness and Wellness Centers, Gym, Etc.)

14.6.7. Southeast Asia

14.6.7.1.  Southeast Asia Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Products

14.6.7.1.1. Software

14.6.7.1.2. Devices

14.6.7.2.  Southeast Asia Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Application

14.6.7.2.1. Cardiovascular Diseases

14.6.7.2.2. Central Nervous System (CNS) Diseases

14.6.7.2.3. Diabetes

14.6.7.2.4. Gastrointestinal Disorders (GID)

14.6.7.2.5. Mental Health

14.6.7.2.6. Neurology

14.6.7.2.7. Obesity

14.6.7.2.8. Ophthalmology

14.6.7.2.9. Respiratory Diseases

14.6.7.2.10. Smoking Cessation

14.6.7.2.11. Others

14.6.7.3.  Southeast Asia Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

14.6.7.3.1. Business to Business

14.6.7.3.2. Business to Customer

14.6.7.4.  Southeast Asia Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By End User

14.6.7.4.1. Patients

14.6.7.4.2. Healthcare Providers

14.6.7.4.3. Payers

14.6.7.4.4. Employers

14.6.7.4.5. Other (Fitness and Wellness Centers, Gym, Etc.)

14.6.7.5.  Southeast Asia Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Country

14.6.7.5.1. Indonesia

14.6.7.5.2. Thailand

14.6.7.5.3. Malaysia

14.6.7.5.4. Singapore

14.6.7.5.5. Rest of Southeast Asia

14.6.8. Rest of Asia Pacific

14.6.8.1.  Rest of Asia Pacific Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Products

14.6.8.1.1. Software

14.6.8.1.2. Devices

14.6.8.2.  Rest of Asia Pacific Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Application

14.6.8.2.1. Cardiovascular Diseases

14.6.8.2.2. Central Nervous System (CNS) Diseases

14.6.8.2.3. Diabetes

14.6.8.2.4. Gastrointestinal Disorders (GID)

14.6.8.2.5. Mental Health

14.6.8.2.6. Neurology

14.6.8.2.7. Obesity

14.6.8.2.8. Ophthalmology

14.6.8.2.9. Respiratory Diseases

14.6.8.2.10. Smoking Cessation

14.6.8.2.11. Others

14.6.8.3.  Rest of Asia Pacific Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

14.6.8.3.1. Business to Business

14.6.8.3.2. Business to Customer

14.6.8.4.  Rest of Asia Pacific Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By End User

14.6.8.4.1. Patients

14.6.8.4.2. Healthcare Providers

14.6.8.4.3. Payers

14.6.8.4.4. Employers

14.6.8.4.5. Other (Fitness and Wellness Centers, Gym, Etc.)

14.7. Key Segment for Channeling Investments

14.7.1. By Country

14.7.2. By Products

14.7.3. By Application

14.7.4. By Distribution Channel

14.7.5. By End User

15. Middle East and Africa Digital Therapeutics Market Analysis and Forecasts, 2019 - 2027

15.1. Overview

15.1.1. Middle East and Africa Digital Therapeutics Market Revenue (US$ Mn)

15.2. Middle East and Africa Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Products

15.2.1. Software

15.2.2. Devices

15.3. Middle East and Africa Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Application

15.3.1. Cardiovascular Diseases

15.3.2. Central Nervous System (CNS) Diseases

15.3.3. Diabetes

15.3.4. Gastrointestinal Disorders (GID)

15.3.5. Mental Health

15.3.6. Neurology

15.3.7. Obesity

15.3.8. Ophthalmology

15.3.9. Respiratory Diseases

15.3.10. Smoking Cessation

15.3.11. Others

15.4. Middle East and Africa Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

15.4.1. Business to Business

15.4.2. Business to Customer

15.5. Middle East and Africa Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By End User

15.5.1. Patients

15.5.2. Healthcare Providers

15.5.3. Payers

15.5.4. Employers

15.5.5. Other (Fitness and Wellness Centers, Gym, Etc.)

15.6. Middle East and Africa Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Country

15.6.1. Saudi Arabia

15.6.1.1.  Saudi Arabia Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Products

15.6.1.1.1. Software

15.6.1.1.2. Devices

15.6.1.2.  Saudi Arabia Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Application

15.6.1.2.1. Cardiovascular Diseases

15.6.1.2.2. Central Nervous System (CNS) Diseases

15.6.1.2.3. Diabetes

15.6.1.2.4. Gastrointestinal Disorders (GID)

15.6.1.2.5. Mental Health

15.6.1.2.6. Neurology

15.6.1.2.7. Obesity

15.6.1.2.8. Ophthalmology

15.6.1.2.9. Respiratory Diseases

15.6.1.2.10. Smoking Cessation

15.6.1.2.11. Others

15.6.1.3.  Saudi Arabia Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

15.6.1.3.1. Business to Business

15.6.1.3.2. Business to Customer

15.6.1.4.  Saudi Arabia Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By End User

15.6.1.4.1. Patients

15.6.1.4.2. Healthcare Providers

15.6.1.4.3. Payers

15.6.1.4.4. Employers

15.6.1.4.5. Other (Fitness and Wellness Centers, Gym, Etc.)

15.6.2. UAE

15.6.2.1.  UAE Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Products

15.6.2.1.1. Software

15.6.2.1.2. Devices

15.6.2.2.  UAE Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Application

15.6.2.2.1. Cardiovascular Diseases

15.6.2.2.2. Central Nervous System (CNS) Diseases

15.6.2.2.3. Diabetes

15.6.2.2.4. Gastrointestinal Disorders (GID)

15.6.2.2.5. Mental Health

15.6.2.2.6. Neurology

15.6.2.2.7. Obesity

15.6.2.2.8. Ophthalmology

15.6.2.2.9. Respiratory Diseases

15.6.2.2.10. Smoking Cessation

15.6.2.2.11. Others

15.6.2.3.  UAE Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

15.6.2.3.1. Business to Business

15.6.2.3.2. Business to Customer

15.6.2.4.  UAE Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By End User

15.6.2.4.1. Patients

15.6.2.4.2. Healthcare Providers

15.6.2.4.3. Payers

15.6.2.4.4. Employers

15.6.2.4.5. Other (Fitness and Wellness Centers, Gym, Etc.)

15.6.3. Egypt

15.6.3.1.  Egypt Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Products

15.6.3.1.1. Software

15.6.3.1.2. Devices

15.6.3.2.  Egypt Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Application

15.6.3.2.1. Cardiovascular Diseases

15.6.3.2.2. Central Nervous System (CNS) Diseases

15.6.3.2.3. Diabetes

15.6.3.2.4. Gastrointestinal Disorders (GID)

15.6.3.2.5. Mental Health

15.6.3.2.6. Neurology

15.6.3.2.7. Obesity

15.6.3.2.8. Ophthalmology

15.6.3.2.9. Respiratory Diseases

15.6.3.2.10. Smoking Cessation

15.6.3.2.11. Others

15.6.3.3.  Egypt Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

15.6.3.3.1. Business to Business

15.6.3.3.2. Business to Customer

15.6.3.4.  Egypt Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By End User

15.6.3.4.1. Patients

15.6.3.4.2. Healthcare Providers

15.6.3.4.3. Payers

15.6.3.4.4. Employers

15.6.3.4.5. Other (Fitness and Wellness Centers, Gym, Etc.)

15.6.4. Kuwait

15.6.4.1.  Kuwait Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Products

15.6.4.1.1. Software

15.6.4.1.2. Devices

15.6.4.2.  Kuwait Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Application

15.6.4.2.1. Cardiovascular Diseases

15.6.4.2.2. Central Nervous System (CNS) Diseases

15.6.4.2.3. Diabetes

15.6.4.2.4. Gastrointestinal Disorders (GID)

15.6.4.2.5. Mental Health

15.6.4.2.6. Neurology

15.6.4.2.7. Obesity

15.6.4.2.8. Ophthalmology

15.6.4.2.9. Respiratory Diseases

15.6.4.2.10. Smoking Cessation

15.6.4.2.11. Others

15.6.4.3.  Kuwait Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

15.6.4.3.1. Business to Business

15.6.4.3.2. Business to Customer

15.6.4.4.  Kuwait Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By End User

15.6.4.4.1. Patients

15.6.4.4.2. Healthcare Providers

15.6.4.4.3. Payers

15.6.4.4.4. Employers

15.6.4.4.5. Other (Fitness and Wellness Centers, Gym, Etc.)

15.6.5. South Africa

15.6.5.1.  South Africa Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Products

15.6.5.1.1. Software

15.6.5.1.2. Devices

15.6.5.2.  South Africa Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Application

15.6.5.2.1. Cardiovascular Diseases

15.6.5.2.2. Central Nervous System (CNS) Diseases

15.6.5.2.3. Diabetes

15.6.5.2.4. Gastrointestinal Disorders (GID)

15.6.5.2.5. Mental Health

15.6.5.2.6. Neurology

15.6.5.2.7. Obesity

15.6.5.2.8. Ophthalmology

15.6.5.2.9. Respiratory Diseases

15.6.5.2.10. Smoking Cessation

15.6.5.2.11. Others

15.6.5.3.  South Africa Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

15.6.5.3.1. Business to Business

15.6.5.3.2. Business to Customer

15.6.5.4.  South Africa Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By End User

15.6.5.4.1. Patients

15.6.5.4.2. Healthcare Providers

15.6.5.4.3. Payers

15.6.5.4.4. Employers

15.6.5.4.5. Other (Fitness and Wellness Centers, Gym, Etc.)

15.6.6. Rest of Middle East & Africa

15.6.6.1.  Rest of Middle East & Africa Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Products

15.6.6.1.1. Software

15.6.6.1.2. Devices

15.6.6.2.  Rest of Middle East & Africa Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Application

15.6.6.2.1. Cardiovascular Diseases

15.6.6.2.2. Central Nervous System (CNS) Diseases

15.6.6.2.3. Diabetes

15.6.6.2.4. Gastrointestinal Disorders (GID)

15.6.6.2.5. Mental Health

15.6.6.2.6. Neurology

15.6.6.2.7. Obesity

15.6.6.2.8. Ophthalmology

15.6.6.2.9. Respiratory Diseases

15.6.6.2.10. Smoking Cessation

15.6.6.2.11. Others

15.6.6.3.  Rest of Middle East & Africa Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

15.6.6.3.1. Business to Business

15.6.6.3.2. Business to Customer

15.6.6.4.  Rest of Middle East & Africa Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By End User

15.6.6.4.1. Patients

15.6.6.4.2. Healthcare Providers

15.6.6.4.3. Payers

15.6.6.4.4. Employers

15.6.6.4.5. Other (Fitness and Wellness Centers, Gym, Etc.)

15.7. Key Segment for Channeling Investments

15.7.1. By Country

15.7.2. By Products

15.7.3. By Application

15.7.4. By Distribution Channel

15.7.5. By End User

16. Latin America Digital Therapeutics Market Analysis and Forecasts, 2019 - 2027

16.1. Overview

16.1.1. Latin America Digital Therapeutics Market Revenue (US$ Mn)

16.2. Latin America Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Products

16.2.1. Software

16.2.2. Devices

16.3. Latin America Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Application

16.3.1. Cardiovascular Diseases

16.3.2. Central Nervous System (CNS) Diseases

16.3.3. Diabetes

16.3.4. Gastrointestinal Disorders (GID)

16.3.5. Mental Health

16.3.6. Neurology

16.3.7. Obesity

16.3.8. Ophthalmology

16.3.9. Respiratory Diseases

16.3.10. Smoking Cessation

16.3.11. Others

16.4. Latin America Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

16.4.1. Business to Business

16.4.2. Business to Customer

16.5. Latin America Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By End User

16.5.1. Patients

16.5.2. Healthcare Providers

16.5.3. Payers

16.5.4. Employers

16.5.5. Other (Fitness and Wellness Centers, Gym, Etc.)

16.6. Latin America Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Country

16.6.1. Brazil

16.6.1.1.  Brazil Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Products

16.6.1.1.1. Software

16.6.1.1.2. Devices

16.6.1.2.  Brazil Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Application

16.6.1.2.1. Cardiovascular Diseases

16.6.1.2.2. Central Nervous System (CNS) Diseases

16.6.1.2.3. Diabetes

16.6.1.2.4. Gastrointestinal Disorders (GID)

16.6.1.2.5. Mental Health

16.6.1.2.6. Neurology

16.6.1.2.7. Obesity

16.6.1.2.8. Ophthalmology

16.6.1.2.9. Respiratory Diseases

16.6.1.2.10. Smoking Cessation

16.6.1.2.11. Others

16.6.1.3.  Brazil Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

16.6.1.3.1. Business to Business

16.6.1.3.2. Business to Customer

16.6.1.4.  Brazil Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By End User

16.6.1.4.1. Patients

16.6.1.4.2. Healthcare Providers

16.6.1.4.3. Payers

16.6.1.4.4. Employers

16.6.1.4.5. Other (Fitness and Wellness Centers, Gym, Etc.)

16.6.2. Argentina

16.6.2.1.  Argentina Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Products

16.6.2.1.1. Software

16.6.2.1.2. Devices

16.6.2.2.  Argentina Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Application

16.6.2.2.1. Cardiovascular Diseases

16.6.2.2.2. Central Nervous System (CNS) Diseases

16.6.2.2.3. Diabetes

16.6.2.2.4. Gastrointestinal Disorders (GID)

16.6.2.2.5. Mental Health

16.6.2.2.6. Neurology

16.6.2.2.7. Obesity

16.6.2.2.8. Ophthalmology

16.6.2.2.9. Respiratory Diseases

16.6.2.2.10. Smoking Cessation

16.6.2.2.11. Others

16.6.2.3.  Argentina Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

16.6.2.3.1. Business to Business

16.6.2.3.2. Business to Customer

16.6.2.4.  Argentina Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By End User

16.6.2.4.1. Patients

16.6.2.4.2. Healthcare Providers

16.6.2.4.3. Payers

16.6.2.4.4. Employers

16.6.2.4.5. Other (Fitness and Wellness Centers, Gym, Etc.)

16.6.3. Rest of Latin America

16.6.3.1.  Rest of Latin America Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Products

16.6.3.1.1. Software

16.6.3.1.2. Devices

16.6.3.2.  Rest of Latin America Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Application

16.6.3.2.1. Cardiovascular Diseases

16.6.3.2.2. Central Nervous System (CNS) Diseases

16.6.3.2.3. Diabetes

16.6.3.2.4. Gastrointestinal Disorders (GID)

16.6.3.2.5. Mental Health

16.6.3.2.6. Neurology

16.6.3.2.7. Obesity

16.6.3.2.8. Ophthalmology

16.6.3.2.9. Respiratory Diseases

16.6.3.2.10. Smoking Cessation

16.6.3.2.11. Others

16.6.3.3.  Rest of Latin America Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

16.6.3.3.1. Business to Business

16.6.3.3.2. Business to Customer

16.6.3.4.  Rest of Latin America Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By End User

16.6.3.4.1. Patients

16.6.3.4.2. Healthcare Providers

16.6.3.4.3. Payers

16.6.3.4.4. Employers

16.6.3.4.5. Other (Fitness and Wellness Centers, Gym, Etc.)

16.7. Key Segment for Channeling Investments

16.7.1. By Country

16.7.2. By Products

16.7.3. By Application

16.7.4. By Distribution Channel

16.7.5. By End User

17. Competitive Benchmarking

17.1. Brand Benchmarking

17.2. Market Share Analysis, 2018

17.3. Global Presence and Growth Strategies

17.3.1. Mergers and Acquisitions

17.3.2. Product Launches

17.3.3. Investments Trends

17.3.4. R&D Initiatives

18. Player Profiles

18.1. Adherium

18.1.1. Company Details

18.1.2. Company Overview

18.1.3. Product Offerings

18.1.4. Key Developments

18.1.5. Financial Analysis

18.1.6. SWOT Analysis

18.1.7. Business Strategies

18.2. BigHealth

18.2.1. Company Details

18.2.2. Company Overview

18.2.3. Product Offerings

18.2.4. Key Developments

18.2.5. Financial Analysis

18.2.6. SWOT Analysis

18.2.7. Business Strategies

18.3. BLUE MESA HEALTH

18.3.1. Company Details

18.3.2. Company Overview

18.3.3. Product Offerings

18.3.4. Key Developments

18.3.5. Financial Analysis

18.3.6. SWOT Analysis

18.3.7. Business Strategies

18.4. CANARY HEALTH

18.4.1. Company Details

18.4.2. Company Overview

18.4.3. Product Offerings

18.4.4. Key Developments

18.4.5. Financial Analysis

18.4.6. SWOT Analysis

18.4.7. Business Strategies

18.5. Chrono Therapeutics Inc.,

18.5.1. Company Details

18.5.2. Company Overview

18.5.3. Product Offerings

18.5.4. Key Developments

18.5.5. Financial Analysis

18.5.6. SWOT Analysis

18.5.7. Business Strategies

18.6. Diabetes Digital Media Ltd

18.6.1. Company Details

18.6.2. Company Overview

18.6.3. Product Offerings

18.6.4. Key Developments

18.6.5. Financial Analysis

18.6.6. SWOT Analysis

18.6.7. Business Strategies

18.7. Digital Therapeutics, Inc.

18.7.1. Company Details

18.7.2. Company Overview

18.7.3. Product Offerings

18.7.4. Key Developments

18.7.5. Financial Analysis

18.7.6. SWOT Analysis

18.7.7. Business Strategies

18.8. Dthera Sciences

18.8.1. Company Details

18.8.2. Company Overview

18.8.3. Product Offerings

18.8.4. Key Developments

18.8.5. Financial Analysis

18.8.6. SWOT Analysis

18.8.7. Business Strategies

18.9. Firstbeat

18.9.1. Company Details

18.9.2. Company Overview

18.9.3. Product Offerings

18.9.4. Key Developments

18.9.5. Financial Analysis

18.9.6. SWOT Analysis

18.9.7. Business Strategies

18.10. GINGER.IO

18.10.1. Company Details

18.10.2. Company Overview

18.10.3. Product Offerings

18.10.4. Key Developments

18.10.5. Financial Analysis

18.10.6. SWOT Analysis

18.10.7. Business Strategies

18.11. Glooko, Inc.

18.11.1. Company Details

18.11.2. Company Overview

18.11.3. Product Offerings

18.11.4. Key Developments

18.11.5. Financial Analysis

18.11.6. SWOT Analysis

18.11.7. Business Strategies

18.12. Limbix

18.12.1. Company Details

18.12.2. Company Overview

18.12.3. Product Offerings

18.12.4. Key Developments

18.12.5. Financial Analysis

18.12.6. SWOT Analysis

18.12.7. Business Strategies

18.13. Livongo Health

18.13.1. Company Details

18.13.2. Company Overview

18.13.3. Product Offerings

18.13.4. Key Developments

18.13.5. Financial Analysis

18.13.6. SWOT Analysis

18.13.7. Business Strategies

18.14. MANGO HEALTH

18.14.1. Company Details

18.14.2. Company Overview

18.14.3. Product Offerings

18.14.4. Key Developments

18.14.5. Financial Analysis

18.14.6. SWOT Analysis

18.14.7. Business Strategies

18.15. Merck & Co., Inc.

18.15.1. Company Details

18.15.2. Company Overview

18.15.3. Product Offerings

18.15.4. Key Developments

18.15.5. Financial Analysis

18.15.6. SWOT Analysis

18.15.7. Business Strategies

18.16. Noom, Inc.

18.16.1. Company Details

18.16.2. Company Overview

18.16.3. Product Offerings

18.16.4. Key Developments

18.16.5. Financial Analysis

18.16.6. SWOT Analysis

18.16.7. Business Strategies

18.17. Novartis AG

18.17.1. Company Details

18.17.2. Company Overview

18.17.3. Product Offerings

18.17.4. Key Developments

18.17.5. Financial Analysis

18.17.6. SWOT Analysis

18.17.7. Business Strategies

18.18. Omada Health, Inc.

18.18.1. Company Details

18.18.2. Company Overview

18.18.3. Product Offerings

18.18.4. Key Developments

18.18.5. Financial Analysis

18.18.6. SWOT Analysis

18.18.7. Business Strategies

18.19. Propeller Health

18.19.1. Company Details

18.19.2. Company Overview

18.19.3. Product Offerings

18.19.4. Key Developments

18.19.5. Financial Analysis

18.19.6. SWOT Analysis

18.19.7. Business Strategies

18.20. Proteus Digital Health

18.20.1. Company Details

18.20.2. Company Overview

18.20.3. Product Offerings

18.20.4. Key Developments

18.20.5. Financial Analysis

18.20.6. SWOT Analysis

18.20.7. Business Strategies

18.21. WellDoc, Inc.

18.21.1. Company Details

18.21.2. Company Overview

18.21.3. Product Offerings

18.21.4. Key Developments

18.21.5. Financial Analysis

18.21.6. SWOT Analysis

18.21.7. Business Strategies

19. Key Findings

 

Note: This ToC is tentative and can be changed according to the research study conducted during the course of report completion.

 

**Exclusive for Multi-User and Enterprise User
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets. 
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.  
Prominent participants in our primary research process include:
  • Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
  • Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
  • Reuters
  • Factiva
  • Bloomberg
  • One Source
  • Hoovers
 
Research Methodology
Methodology
Key Inclusions
Methodology

  • A PHP Error was encountered

    Severity: Notice

    Message: Undefined offset: 0

    Filename: pages/reportpage.php

    Line Number: 163

    Backtrace:

    File: /var/www/html/ami/application/views/pages/reportpage.php
    Line: 163
    Function: _error_handler

    File: /var/www/html/ami/application/controllers/Report.php
    Line: 153
    Function: view

    File: /var/www/html/ami/index.php
    Line: 315
    Function: require_once



Request For Customization Enquiry Before Buying Get Sample Pages